多参数肾脏MRI预测CKD进展的前瞻性研究(AFiRM)
AFiRM是一项多中心前瞻性观察队列研究,纳入420例CKD患者,采用UKRIN-MAPS方案进行基线及2年肾脏多参数MRI,并随访临床数据4年、肾脏衰竭结局10年。主要目标是评估MRI形态、炎症、纤维化、灌注和氧合指标与CKD进展的关联,并量化纵向变化;活检亚组比较MRI与组织学。
要点
- AFiRM建立了代表性CKD队列,接受先进肾脏mpMRI及长期随访。
- 主要结局为MRI指标与CKD进展的关联及纵向变化。
- 活检亚组探索mpMRI与组织学纤维化等机制的对应关系。
核心结论
- AFiRM研究已建立接受先进肾脏mpMRI并长期随访的代表性CKD队列,是研究肾脏MRI指标及其纵向变化与CKD严重程度和进展关系的重要资源。
研究设计与样本
- 多中心、前瞻性、观察性队列研究(AFiRM;NCT04238299),在CKD患者中于基线和2年时采用UKRIN-MAPS协议行肾脏mpMRI。
- 临床数据每年收集持续4年,肾脏衰竭结局评估至10年;活检亚组比较mpMRI与组织学。
- 共9个中心,420例参与者完成基线评估和mpMRI,其中活检亚组43例。
主要发现
- 参与者平均年龄55岁(SD 13),63.8%为男性。
- 中位eGFR为39 ml/min per 1.73 m2(IQR 29-53),中位uACR为47 mg/mmol(IQR 8.3-127.1),中位5年肾脏衰竭风险方程评分为5.6%(IQR 1.0-20.8%)。
- 最常见CKD病因依次为IgA肾病(22.4%)、不明病因CKD(19.5%)和糖尿病肾病(14.3%);活检亚组人口学特征与全队列相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic kidney disease (CKD) has major population health implications, but current imaging approaches provide limited pathophysiological insights. We designed a study to evaluate renal multiparametric magnetic resonance imaging (MRI; mpMRI) as a tool to improve diagnosis, risk stratification, disease monitoring, and therapeutic decision-making in CKD. METHODS: The application of functional renal MRI to improve assessment of CKD (AFiRM study; NCT04238299) is a multicenter, prospective, observational cohort study in people with CKD. Participants underwent renal mpMRI using the harmonized cross-vendor UK Renal Imaging Network: MRI Acquisition and Processing Standardization (UKRIN-MAPS) protocol at baseline and at 2-years. Clinical data are collected annually for 4 years with kidney failure outcomes assessed at 10 years. Primary objectives are to determine associations between MRI measures of kidney morphology, inflammation, fibrosis, perfusion, and oxygenation with CKD progression, and to quantify longitudinal changes in mpMRI measures. A biopsy substudy compares mpMRI measures with histology to explore mechanistic processes including fibrosis. RESULTS: Across 9 centers, 420 participants (biopsy substudy n = 43) completed baseline assessments and mpMRI. Mean age is 55 years (SD 13), and 63.8% are male. Median estimated glomerular filtration rate (eGFR) is 39 ml/min per 1.73 m2 (IQR 29-53), median urine albumin-creatinine ratio (uACR) 47 mg/mmol (IQR 8.3-127.1), and median 5-year Kidney Failure Risk Equation score is 5.6% (IQR 1.0-20.8%). Most common CKD etiologies are IgA nephropathy (22.4%), CKD of unknown etiology (19.5%), and diabetic kidney disease (14.3%). Biopsy substudy participants were demographically similar to the full cohort. CONCLUSION: The AFiRM study has established a representative CKD cohort undergoing advanced renal mpMRI with long-term follow-up. This is an important resource to study how renal MRI measures and their longitudinal changes relate to CKD severity and progression.
引用
- Francis S, Buchanan CE, Chester V, et al. Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM). Kidney Int Rep. 2026. PMID: 42375700. doi:10.1016/j.ekir.2026.106594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。